Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Cystic Fibrosis; Digestive System Diseases; Exocrine Pancreatic Insufficiency; Fibrosis; Gastrointestinal Diseases; Lung Diseases; Respiratory Tract Diseases | Phase 1/Phase 2 | ClinicalTrials |
CONTENTS